Nextage Therapeutics Ltd (NXTG.TA)
ILA 72.8
(-3.45%)
ILA 72.8
(-3.45%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.26 Million | -6.01 Million | -2.4 Million | -7.18 Million | -5 Million | -4.95 Million |
| Net Income | -4.2 Million | -5.98 Million | -7.72 Million | -6.62 Million | -2.11 Million | -8.74 Million |
| Depreciation & Amortization | 128 Thousand | 57 Thousand | 190 Thousand | 96 Thousand | 161 Thousand | 4.44 Million |
| Deferred income taxes | -27 Thousand | -48 Thousand | 2.15 Million | -96 Thousand | - | - |
| Stock-based compensation | 90 Thousand | 465 Thousand | 2.02 Million | 3.44 Million | 119 Thousand | 73 Thousand |
| Change in working capital | 1.74 Million | -516 Thousand | 4.54 Million | -3.08 Million | -853 Thousand | 592 Thousand |
| Other non-cash items | 5000.00 | 15 Thousand | -3.58 Million | -929 Thousand | -2.32 Million | -1.31 Million |
| Investing Cash Flow | 3000.00 | 17 Thousand | -5.09 Million | 149 Thousand | 13 Thousand | -4000.00 |
| Investments in PPE | - | -4000.00 | - | -10 Thousand | -1000.00 | -4000.00 |
| Acquisitions | - | - | -5.03 Million | 7.97 Million | - | - |
| Investment purchases | - | - | -64 Thousand | -16 Thousand | - | - |
| Sales/Maturities of investments | 3000.00 | 21 Thousand | - | -7.95 Million | - | - |
| Other Investing Activities | - | - | -64 Thousand | 149 Thousand | 14 Thousand | - |
| Financing Cash Flow | 1.47 Million | 3.39 Million | 5.46 Million | 7.7 Million | 5.59 Million | 2.58 Million |
| Debt repayment | -210 Thousand | -202 Thousand | -193 Thousand | -1.79 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.16 Million | 3.44 Million | 4.8 Million | 7.7 Million | 5.59 Million | 2.58 Million |
| Other Financing Activities | 526 Thousand | 151 Thousand | 856 Thousand | 1.79 Million | - | - |
| Accounts receivables | -113 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.85 Million | - | - | - | - | - |
| Cash at beginning of period | 1.05 Million | 3.26 Million | 1.58 Million | 917 Thousand | 481 Thousand | 2.85 Million |
| Cash at end of period | 404 Thousand | 1.05 Million | -664 Thousand | 1.58 Million | 1.08 Million | 481 Thousand |
| Capital Expenditure | - | -4000.00 | - | -10 Thousand | -1000.00 | -4000.00 |
| Effect of forex changes on cash | 134 Thousand | 391 Thousand | -213 Thousand | - | - | - |
| Net cash flow / Change in cash | -647 Thousand | -2.21 Million | -2.24 Million | 668 Thousand | 599 Thousand | -2.37 Million |
| Free Cash Flow | -2.26 Million | -6.01 Million | -2.4 Million | -7.19 Million | -5 Million | -4.95 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.2 Million | -1.64 Million | -2.23 Million | -5.98 Million | -2.79 Million | -2.79 Million |
| Depreciation & Amortization | 128 Thousand | 399 Thousand | -271 Thousand | 57 Thousand | 19 Thousand | 38 Thousand |
| Deferred income taxes | -27 Thousand | - | - | -48 Thousand | - | - |
| Stock-based compensation | 90 Thousand | - | - | 465 Thousand | - | - |
| Change in working capital | 1.74 Million | 1.4 Million | 339 Thousand | -516 Thousand | 281 Thousand | -797 Thousand |
| Other non-cash items | 5000.00 | 457 Thousand | -332 Thousand | 15 Thousand | -53 Thousand | 248 Thousand |
| Investing Cash Flow | 3000.00 | 9000.00 | -6000.00 | 17 Thousand | 6000.00 | 11 Thousand |
| Investments in PPE | - | - | - | -4000.00 | -4000.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | 6000.00 | -6000.00 | - | - | - |
| Sales/Maturities of investments | 3000.00 | - | - | 21 Thousand | 10 Thousand | 11 Thousand |
| Other Investing Activities | - | 3000.00 | - | - | - | - |
| Financing Cash Flow | 1.47 Million | 688 Thousand | 790 Thousand | 3.39 Million | -99 Thousand | 3.49 Million |
| Debt repayment | -210 Thousand | -511 Thousand | -101 Thousand | -202 Thousand | -94 Thousand | -68 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.16 Million | 224 Thousand | 938 Thousand | 3.44 Million | - | 3.44 Million |
| Other Financing Activities | 526 Thousand | -47 Thousand | -47 Thousand | 151 Thousand | -5000.00 | - |
| Accounts receivables | - | -209 Thousand | 96 Thousand | - | 2000.00 | 264 Thousand |
| Accounts payables | - | 67 Thousand | -79 Thousand | - | 12 Thousand | -322 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | 1.54 Million | 322 Thousand | - | 267 Thousand | -739 Thousand |
| Cash at beginning of period | 1.05 Million | 3000.00 | 1.05 Million | 3.26 Million | 3.63 Million | 5.18 Million |
| Cash at end of period | 404 Thousand | 404 Thousand | 3000.00 | 1.05 Million | 1.05 Million | 3.63 Million |
| Capital Expenditure | - | - | - | -4000.00 | -4000.00 | - |
| Effect of forex changes on cash | 134 Thousand | 22 Thousand | 112 Thousand | 391 Thousand | 83 Thousand | -1.61 Million |
| Net cash flow / Change in cash | -647 Thousand | 401 Thousand | -1.04 Million | -2.21 Million | -2.58 Million | -1.55 Million |
| Free Cash Flow | -2.26 Million | -318 Thousand | -1.94 Million | -6.01 Million | -2.57 Million | -3.44 Million |
HMSB
0R2J
ARU
PGE
SAMRATPH
GEODF